Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)
Keywords: TLR, toll-like receptor; IFN, interferon; RRMS, relapsing-remitting multiple sclerosis; IFNAR, IFN receptor; HC, healthy control; LOX, loxorubin; CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; Treg, T regulatory cells; Breg,